UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 25 filers reported holding UROVANT SCIENCES LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,488,000 | +39.1% | 160,442 | -15.0% | 0.59% | +3.0% |
| Q3 2019 | $1,788,000 | +2.7% | 188,842 | -14.2% | 0.58% | +37.1% |
| Q2 2019 | $1,741,000 | -19.4% | 220,042 | +2.3% | 0.42% | -28.0% |
| Q1 2019 | $2,161,000 | -59.4% | 215,042 | -73.4% | 0.58% | -69.9% |
| Q4 2018 | $5,324,000 | -25.0% | 807,860 | +36.6% | 1.94% | -20.4% |
| Q3 2018 | $7,097,000 | – | 591,454 | – | 2.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|